[HTML][HTML] Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection
Methods A multidisciplinary working group drafted a management algorithm for advanced
urothelial carcinoma using “consensus development conference” methodology. A targeted …
urothelial carcinoma using “consensus development conference” methodology. A targeted …
Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection
PC Black, NS Alimohamed… - … = Journal de l' …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction Advanced urothelial carcinoma has been challenging to treat due to limited
treatment options, poor response rates, and poor long-term survival. New treatment options …
treatment options, poor response rates, and poor long-term survival. New treatment options …
Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection.
PC Black, NS Alimohamed, D Berman… - … Journal= Journal de …, 2020 - europepmc.org
Methods A multidisciplinary working group drafted a management algorithm for advanced
urothelial carcinoma using" consensus development conference" methodology. A targeted …
urothelial carcinoma using" consensus development conference" methodology. A targeted …
Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection.
PC Black, NS Alimohamed, D Berman… - Canadian Urological …, 2020 - go.gale.com
Introduction: Advanced urothelial carcinoma has been challenging to treat due to limited
treatment options, poor response rates, and poor long-term survival. New treatment options …
treatment options, poor response rates, and poor long-term survival. New treatment options …
Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection
PC Black, NS Alimohamed, D Berman, N Blais… - Canadian Urological …, 2020 - cuaj.ca
Introduction: Advanced urothelial carcinoma has been challenging to treat due to limited
treatment options, poor response rates, and poor long-term survival. New treatment options …
treatment options, poor response rates, and poor long-term survival. New treatment options …
[PDF][PDF] Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection
PC Black, NS Alimohamed, D Berman, N Blais, B Eigl… - 2020 - cuaj.ca
Introduction: Advanced urothelial carcinoma has been challenging to treat due to limited
treatment options, poor response rates, and poor long-term survival. New treatment options …
treatment options, poor response rates, and poor long-term survival. New treatment options …
Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection.
PC Black, NS Alimohamed, D Berman… - … Journal= Journal de …, 2020 - europepmc.org
Methods A multidisciplinary working group drafted a management algorithm for advanced
urothelial carcinoma using" consensus development conference" methodology. A targeted …
urothelial carcinoma using" consensus development conference" methodology. A targeted …